Adult
Aged
Aged, 80 and over
Antineoplastic Agents/therapeutic use
Carcinoma, Papillary/*drug therapy/immunology/secondary
Carcinoma, Renal Cell/*drug therapy/immunology/secondary
Drug Therapy, Combination
Female
Humans
Immunologic Factors/therapeutic use
*Immunotherapy
Interferon-alpha/*therapeutic use
Interleukin-2/*therapeutic use
Kidney Neoplasms/*drug therapy/immunology/pathology
Male
Middle Aged
Neoplasm Staging
Prognosis
Survival Rate
Treatment Outcome
